Signature Genomic Laboratories Announces Release of Enhanced Microarray for Prenatal Diagnosis
Posted on: Wednesday, 5 November 2008, 12:00 CST
Signature Genomic Laboratories announced the release of an enhanced microarray for the prenatal detection of chromosome abnormalities that result in missing or extra pieces of DNA.
The first tier of Signature's Prenatal Service, the enhanced PrenatalChip(R) targets over 100 discrete chromosomal regions, the gain or loss of which results in a genetic disorder, while minimizing coverage of regions of unknown clinical significance. Signature's whole-genome microarray, the SignatureChipWG, can be ordered if more coverage is required -- especially in cases with abnormal findings by ultrasound.
"Pregnancy can be a time of great anxiety, particularly if a genetic disorder is suspected," said Justine Coppinger, Certified Genetic Counselor at Signature. "We approach prenatal diagnosis responsibly, balancing timely, comprehensive diagnoses with the desire to minimize anxiety over unclear results. We encourage physicians to discuss the most appropriate test for their patients with our certified genetic counselors."
About Signature Genomic Laboratories
Signature Genomic Laboratories, founded in 2003, was the first laboratory to provide microarray-based cytogenetic diagnostics with its proprietary SignatureChip(R) and is the leader in providing microarray-based chromosome analysis. Signature's worldwide client base includes clinical geneticists, neurologists, pediatricians, neonatologists, obstetricians, and the research community. Signature is CAP accredited, CLIA certified, and has clinical licenses from California, Rhode Island and Florida. Additional information about Signature Genomic Laboratories is available at www.signaturegenomics.com.
Source: Business Wire
Related Articles
- Agendia Opens CLIA-Registered U.S. Genomics Laboratory
- Signature Genomic Laboratories Releases New Microarray for Prenatal Diagnosis
- Researchers at Signature Characterize Previously Unrecognized Genetic Disorder
- Signature Genomic Laboratories Implements New Policy for Insurance Billing
- Signature Genomic Laboratories Introduces Patient Advocacy Program
- Molecular Genetics Are Examined Inside 'Genomics and Genetics: From Molecular Details to Analysis and Techniques'
- LifeWise Improves Well-Being of Moms-to-Be With Grant to PeaceHealth Medical Group Prenatal Clinic
- Signature Genomic Laboratories, LLC(R) and Affymetrix, Inc. Sign License Agreement
- Molecular Nuclear Medicine: The Challenge of Genomics and Proteomics to Clinical Practice
 |
 |
User Comments (0)
RSS Feeds